Announcement on Voluntary Disclosure of Subsidiary Passing On-site Inspection by FDA

About this update from Sichuan Huiyu Pharmaceutical Co. Ltd. Class A

Announcement on Voluntary Disclosure of Subsidiary Passing On-site Inspection by FDA The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Sichuan Huiyu Pharmaceutical Co. Ltd. Class A